00:00<\/b> Bharat Biotech announces over 25,000 volunteers have enrolled for Phase-3 Clinical trials of its vaccine <\/font>

<\/div>
Bharat Biotech, which has been accorded Emergency Use Authorisation from the drug regulator for its COVID-19 vaccine Covaxin, today announced that over 25,000 volunteers have enrolled for Phase-3 Clinical trials of its vaccine, COVAXIN. <\/div>
Announcing successful completion of volunteer enrolment for Phase-3 Clinical trials of COVAXINᵀᴹ.#BharatBiotech<\/a> #COVAXIN<\/a> #clinicaltrials<\/a> #Covid19<\/a> #CovidVaccine<\/a> #phase3<\/a> https:\/\/t.co\/lIdXVpstDK<\/a><\/p>- BharatBiotech (@BharatBiotech) January 7, 2021<\/a><\/blockquote><\/div>","entype":"Text","h":"","img":"","imgalt":"","imgcaption":"","key":"False","link":"","s":18,"sub":"","t":"Jan 07, 2021-15:22:29","title":"

<\/div>
Bharat Biotech, which has been accorded Emergency Use Authorisation from the drug regulator for its COVID-19 vaccine Covaxin, today announced that over 25,000 volunteers have enrolled for Phase-3 Clinical trials of its vaccine, COVAXIN. <\/div>\u000d\u000a\u000d\u000a
Announcing successful completion of volunteer enrolment for Phase-3 Clinical trials of COVAXINᵀᴹ.#BharatBiotech<\/a> #COVAXIN<\/a> #clinicaltrials<\/a> #Covid19<\/a> #CovidVaccine<\/a> #phase3<\/a> https:\/\/t.co\/lIdXVpstDK<\/a><\/p>- BharatBiotech (@BharatBiotech) January 7, 2021<\/a><\/blockquote>","type":"nfeed"});